Osaic Holdings
KNSA icon

Osaic Holdings’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Osaic Holdings’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.7K Buy
1,739
+170
+11% +$7.53K ﹤0.01% 4813
2025
Q4 		$64.7K Buy
1,569
+31
+2% +$1.24K ﹤0.01% 5056
2025
Q3 		$59.7K Buy
1,538
+411
+36% +$13.4K ﹤0.01% 5197
2025
Q2 		$31.2K Buy
+1,127
New +$28.7K ﹤0.01% 5381
2025
Q1 		– Sell
-618
Closed -$12.2K – 7590
2024
Q4 		$12.2K Sell
618
-7
-1% -$160 ﹤0.01% 5656
2024
Q3 		$15.6K Buy
625
+2
+0.3% +$49 ﹤0.01% 5525
2024
Q2 		$11.6K Buy
623
+523
+523% +$9.8K ﹤0.01% 5694
2024
Q1 		$1.97K Sell
100
-946
-90% -$18.5K ﹤0.01% 6476
2023
Q4 		$18.3K Sell
1,046
-253
-19% -$4.16K ﹤0.01% 5536
2023
Q3 		$22.6K Buy
1,299
+315
+32% +$5.31K ﹤0.01% 5491
2023
Q2 		$13.9K Hold
984
– – ﹤0.01% 5792
2023
Q1 		$10.6K Buy
984
+884
+884% +$11.6K ﹤0.01% 5944
2022
Q4 		$1K Hold
100
– – ﹤0.01% 6896
2022
Q3 		$1K Hold
100
– – ﹤0.01% 7006
2022
Q2 		$1K Hold
100
– – ﹤0.01% 7097
2022
Q1 		$1K Buy
+100
New +$1.06K ﹤0.01% 7065
2021
Q4 		– Sell
-269
Closed -$3K – 7483
2021
Q3 		$3K Buy
269
+20
+8% +$260 ﹤0.01% 6738
2021
Q2 		$3K Hold
249
– – ﹤0.01% 6595
2021
Q1 		$5K Buy
+249
New +$5.09K ﹤0.01% 6156
2020
Q2 		– Sell
-100
Closed -$2K – 6228
2020
Q1 		$2K Buy
+100
New +$1.56K ﹤0.01% 5689

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Osaic Holdings's KNSA Position: Q1 2026 in Review

Osaic Holdings increased its Kiniksa Pharmaceuticals (KNSA) stake by 11% in Q1 2026, buying an estimated $7.53K and bringing the position to 1,739 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4813.

Osaic Holdings first reported a position in KNSA in Q1 2020 and has held it in 20 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Osaic Holdings held 1,739 shares of Kiniksa Pharmaceuticals worth $83.7K as of Q1 2026.
  • Osaic Holdings bought 170 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $7.53K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4813 holding.
  • Osaic Holdings first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and has held it in 20 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.